Nxstage medical, inc. (NXTM)
CashFlow / Quarterly
Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11
Cash flows from operating activities:
Net loss

790

-2,221

-1,798

-2,311

-8,894

-2,579

-1,541

-2,419

-890

-2,225

-1,783

-2,801

-2,002

-5,594

-5,863

-4,974

-6,834

-7,195

-5,310

-5,176

-4,986

-3,405

-4,994

-2,364

-2,582

-5,063

-5,144

-4,564

-5,278

-5,550

-6,010

Adjustments to reconcile net loss to net cash flow from operating activities:
Depreciation and amortization

8,684

8,642

8,304

8,433

8,483

8,371

8,467

8,663

8,325

7,913

7,736

7,475

7,767

7,793

7,680

7,402

6,952

6,752

6,591

6,418

6,171

6,179

6,080

6,178

5,915

5,860

5,720

5,672

5,956

5,769

5,690

Stock-based compensation

2,084

2,280

2,697

2,853

3,360

2,750

2,574

2,429

2,294

2,780

2,614

3,008

3,000

2,863

3,727

3,585

3,556

3,099

2,641

808

2,395

2,789

2,646

2,190

2,961

3,053

3,199

2,927

3,465

3,287

3,414

Other

-422

-796

-418

-948

-1,394

-412

623

-3,331

325

524

37

-554

65

-305

-508

-685

-742

-370

-80

-377

-1,025

-996

-230

-470

-702

-1,551

-794

-677

-650

-863

-874

Changes in operating assets and liabilities:
Accounts receivable

31,591

-3,837

2,458

1,387

-1,836

-7,518

6,911

1,887

521

1,131

3,849

-5,430

4,245

2,317

-2

-2,866

-3,873

5,809

5,118

-2,378

1,620

-1,219

3,072

-612

1,902

72

1,779

-1,641

1,661

1,086

667

Inventory

7,982

5,442

7,302

4,763

2,994

7,312

7,848

9,043

9,493

7,053

5,480

1,136

2,954

2,335

5,688

5,277

12,263

9,299

8,224

5,578

2,431

5,717

6,350

2,907

3,829

3,071

4,738

1,175

1,833

6,692

6,671

Prepaid expenses and other assets

971

-789

16

1,649

-876

265

7

689

-471

531

-681

-8

254

-88

-81

1,201

463

157

393

-2,065

-35

1,110

1,474

1,239

214

74

96

-576

1,521

222

324

Accounts payable

4,787

-118

481

1,864

-2,287

-3,799

4,200

-398

1,145

-399

3,184

-2,162

28

-4,291

3,650

-8,509

349

246

7,702

-2,282

-1,906

-2,169

4,124

1,702

83

-914

-32

-3,343

-3,175

1,486

3,985

Accrued expenses and other liabilities

3,825

4,673

-1,417

-488

873

2,420

-4,579

1,126

2,739

1,829

-1,553

699

1,972

1,122

-3,158

2,268

761

1,545

-339

4,928

-2,577

-1,054

-216

1,572

653

1,122

1,916

-519

2,641

1,441

-3,887

Deferred revenues

27,773

519

222

-687

-460

-420

-1,026

-1,519

-1,915

12

979

-2,149

753

-434

-523

81

341

-385

-1,010

820

-1,268

-2,552

-1,887

-543

-2,103

-98

-1,248

332

687

27

602

Net cash provided by operating activities

7,821

13,755

-869

2,813

2,187

7,096

-7,294

-406

1,830

671

2,492

8,926

4,000

-2,800

416

-3,074

-2,986

-10,833

-3,380

4,758

-5,162

-4,824

-4,913

5,671

-316

2,294

-1,408

2,224

-69

-677

-2,994

Cash flows from investing activities:
Cash paid for acquisitions, net of cash acquired

-

-

-

-

-

-

-

0

0

0

513

0

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchases of property and equipment

2,123

1,149

1,092

1,644

2,617

3,328

1,605

2,052

1,330

2,106

3,360

4,384

2,972

2,156

2,025

6,717

4,698

3,767

4,915

5,879

4,999

3,345

2,023

1,742

1,999

2,389

1,564

1,826

1,331

1,376

623

Net cash used in investing activities

-2,123

-1,149

-1,092

-1,644

-5,217

-3,328

-1,605

-2,052

-1,330

-2,106

-3,873

-4,111

-2,569

-2,156

-2,025

-6,717

-4,698

-3,767

-4,915

-5,879

-7,233

-3,345

-2,023

-1,742

-1,999

-2,389

-1,564

-1,826

-1,331

-1,376

-623

Cash flows from financing activities:
Issuance of shares under stock incentive plans, net of payroll taxes paid

417

1,918

-268

984

2,898

3,379

4,742

2,317

1,780

2,003

-106

3,020

1,669

1,007

967

7,598

925

1,150

1,460

2,439

788

1,526

731

-282

1,874

1,541

2,115

1,494

2,573

2,447

1,451

Investment by noncontrolling interest holder

-

-

-

-

-

-

-

45

231

679

300

458

0

471

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Purchase of treasury stock

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

7

2,526

Repayments on loans and lines of credit

14

36

14

38

18

33

75

159

69

89

67

83

16

34

10

36

12

38

12

-

-

-

0

-

-

-

-

0

15

16

15

Repayments on capital leases

410

382

399

325

315

328

338

437

350

391

412

340

329

328

394

346

340

375

387

-

-

0

295

-

-

-

-

-

-

-

-

Net cash provided by financing activities

-7

1,500

-681

621

3,017

3,018

4,329

1,766

1,592

2,202

-285

3,055

1,324

2,391

563

8,131

333

-64

1,061

1,574

1,083

2,662

436

-282

1,874

1,019

2,115

1,494

2,558

2,424

-1,090

Foreign exchange effect on cash and cash equivalents

-34

-438

333

159

153

598

393

-493

266

-22

315

-113

203

-97

-826

-34

-150

-86

-71

522

174

1

-136

113

261

-330

213

-230

-337

125

298

Increase in cash and cash equivalents

5,657

13,668

-2,309

1,949

140

7,384

-4,177

-1,185

2,358

745

-1,351

7,757

2,958

-2,662

-1,872

-1,694

-7,501

-14,750

-7,305

975

-11,138

-5,506

-6,636

3,760

-180

594

-644

1,662

821

496

-4,409

Transfers from inventory to field equipment

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

5,011

3,826

4,595

Transfers from field equipment to deferred cost of revenues

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

3,789

2,932

2,942